Search Results 721-730 of 16065 for pharmacogenetics
About this study. The Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial will determine whether systematically assessing ...
PROFESSIONAL DETAILS. Primary Appointment. Consultant, Division of Infectious Diseases, Department of Internal Medicine ...
The purpose of this study is to identify known and unknown pathogens and antibodies that can cause severe disease in hospitalized patients. Participation ...
About this study. The purpose of this study is to compare the assessment of the composition of the fecal, nasal,oral and skin microbiota in patients with AD ...
The purpose of this study is to test different doses of PTG-300 to identify a dose that is safe and is possibly effective for reducing the need for phlebotomies ...
The purpose of this study is to evaluate the efficacy and the safety/tolerability of poziotinib in patients with NSCLC exon 20 insertion mutations.
About this study. The purpose of this study is to demonstrate whether 4 years of menopausal hormone treatment (MHT) with estrogen initiated at, ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
The Vaccine Research Group at Mayo Clinic provides teaching opportunities to undergraduate, graduate, medical and postdoctoral students.
The secondary aim of this study is to assess the relationship between this digital phenotype and markers of disease severity outcome, including MELD score and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.